<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02715271</url>
  </required_header>
  <id_info>
    <org_study_id>SH-TBL-1</org_study_id>
    <nct_id>NCT02715271</nct_id>
  </id_info>
  <brief_title>Study of TB Lesions Obtained in Therapeutical Surgery</brief_title>
  <acronym>SH-TBL</acronym>
  <official_title>Study of TB Lesions Obtained in Surgery: in Search of Best Biomarkers Correlating With TB Pathology, Clinical Features, MDR Cases and Prognostic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut Germans Trias i Pujol</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Center for Tuberculosis and Lung Diseases (NCTLD); Tbilisi, Georgia.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundació Institut Germans Trias i Pujol</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The correlation of the morphologic, microbiological, genetic and histopathological
      characteristics of TB lesions obtained in therapeutical surgery with the clinical forms and
      features of the patients will provide essential information

        1. on the role of the host in the mechanisms associated to the generation and evolution of
           active TB and

        2. about future diagnostic and/or prognostic biomarkers of TB disease. All this information
           could be used for patients stratification and/or to design new therapeutic strategies.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>15 Days</target_duration>
  <primary_outcome>
    <measure>Description of Clinical and Epidemiological Data of the TB patients enrolled</measure>
    <time_frame>at baseline</time_frame>
    <description>for both the Retrospective and Prospective Substudies; descriptive analysis; data recorded in a spreadsheet created ad-hoc</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Description of the Histopathological characteristics of the TB lesions of TB patients enrolled</measure>
    <time_frame>at baseline</time_frame>
    <description>for both the Retrospective and Prospective Substudies; descriptive analysis; data recorded in a spreadsheet created ad-hoc</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Obtention of a genic-proteomic profile of TB lesions tissues which correlate to the histopathology of the granulomas and/or the clinic-pathological features of TB patients</measure>
    <time_frame>at baseline</time_frame>
    <description>only for Prospective Substudy; descriptive analysis, correlation with histopathological characteristics of TB lesions and with clinical and epidemiological data of TB patients</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Immunological responses</measure>
    <time_frame>at baseline; and at the moment of discharge, an average of at day 15 post-enrollment</time_frame>
    <description>only for Prospective Substudy. Immunological responses will be measured 2.1.3. Identification of biomarkers in blood at protein level in blood and urine; validation in tissue and blood of genic biomarkers secreted (ELISA, qPCR, immunohistochemistry).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Health Quality of Life Measurements</measure>
    <time_frame>at baseline (before surgery) and through study completion, an average of 1 year</time_frame>
    <description>measured with Health Quality of Life Questionnaires; only for Prospective Substudy</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">192</enrollment>
  <condition>Tuberculosis</condition>
  <condition>Thoracic Surgery</condition>
  <condition>Tuberculosis, Pulmonary</condition>
  <condition>Tuberculosis, Multidrug-Resistant</condition>
  <arm_group>
    <arm_group_label>Retrospective cohort</arm_group_label>
    <description>Tuberculosis patients submitted to therapeutical surgery during the last 2-5 years.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Prospective cohort</arm_group_label>
    <description>Tuberculosis patients prospectively submitted to therapeutical surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>therapeutical surgery for TB</intervention_name>
    <description>Patients undergoing therapeutical surgery for tuberculosis (DS- and MDR/XDR-TB) indicated as per clinical routine</description>
    <arm_group_label>Retrospective cohort</arm_group_label>
    <arm_group_label>Prospective cohort</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      For the prospective substudy only:

      The following samples will be prospectively collected from patients undergoing therapeutical
      surgery:

        -  Tissue samples from the TB lesions

        -  plasma

        -  whole blood for RNA studies

        -  urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing therapeutical surgery for their Pulmonary Tuberculosis at NCTLD in
        Tbilisi, Georgia
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing therapeutical surgery for their Pulmonary Tuberculosis at NCTLD in
             Tbilisi, Georgia indicated as per clinical routine

        Exclusion Criteria:

          -  Non consenting to donate samples and/or data for the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cristina Vilaplana, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fundació Institut Germans Trias i Pujol (IGTP)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Center for Tuberculosis and Lung Diseases</name>
      <address>
        <city>Tbilisi</city>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Georgia</country>
  </location_countries>
  <link>
    <url>http://unitatdetuberculosiexperimental.wordpress.com</url>
    <description>website of the Experimental Tuberculosis Unit, Fundacio Institut Germans Trias i Pujol</description>
  </link>
  <results_reference>
    <citation>Vashakidze S, Despuig A, Gogishvili S, Nikolaishvili K, Shubladze N, Avaliani Z, Tukvadze N, Casals M, Caylà JA, Cardona PJ, Vilaplana C. Retrospective study of clinical and lesion characteristics of patients undergoing surgical treatment for Pulmonary Tuberculosis in Georgia. Int J Infect Dis. 2017 Mar;56:200-207. doi: 10.1016/j.ijid.2016.12.009. Epub 2016 Dec 19. Review.</citation>
    <PMID>28007659</PMID>
  </results_reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2016</study_first_submitted>
  <study_first_submitted_qc>March 16, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 22, 2016</study_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fundació Institut Germans Trias i Pujol</investigator_affiliation>
    <investigator_full_name>Cris Vilaplana</investigator_full_name>
    <investigator_title>Senior Researcher at the Experimental Tuberculosis Unit</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
    <mesh_term>Tuberculosis, Pulmonary</mesh_term>
    <mesh_term>Tuberculosis, Multidrug-Resistant</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

